Contraception
Volume 80, Issue 1 , Pages 4-6 , July 2009

An evidence-based approach to postpartum use of depot medroxyprogesterone acetate in breastfeeding women

  • Maria Isabel Rodriguez

      Affiliations

    • Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco and San Francisco General Hospital—6D, San Francisco, CA 94110, USA
    • Corresponding Author InformationCorrresponding author. Tel.: +1 503 349 2417.
    • ,
  • Andrew M. Kaunitz

      Affiliations

    • Department of Obstetrics and Gynecology, University of Florida College of Medicine-Jacksonville, Jacksonville, FL 32209, USA

,Revised 4 December 2008 ,Accepted 4 December 2008.

References 

  1. Glasier A, Brechin S, Raine R, Penney G. A consensus process to adapt the World Health Organization selected practice recommendations for UK use. Contraception. 2003;68:327–333
  2. World Health Organization . Medical Eligibility Criteria for Contraceptive Use. 3rd ed.. Geneva: World Health Organization; 2004;
  3. Speroff L, Mishell DR. The postpartum visit: it's time for a change in order to optimally initiate contraception. Contraception. 2008;78:90–98
  4. Halderman LD, Nelson AL. Impact of early postpartum administration of progestin-only hormonal contraceptives compared with nonhormonal contraceptives on short-term breast-feeding patterns. Am J Obstet Gynecol. 2002;186:1250–1256
  5. Darney P, Speroff L. A clinical guide for contraception. 4th ed.. Philadelphia (PA): Lippincott Williams & Wilkins; 2005;
  6. Tankeyoon M, Dusitsin N, Chalapati S, et al. Effects of hormonal contraceptives on milk volume and infant growth: WHO Special Programme of Research and Development and Research Training in Human Reproduction. Contraception. 1984;30:505–522
  7. World Health Organization , Task Force for Epidemiological Research on Reproductive Health; Special Programme of Research, Development, and Research Training in Human Reproduction . Progestogen-only contraceptives during lactation: II. Infant development. World Contraception. 1994;50:55–68
  8. World Health Organization , Task Force for Epidemiological Research on Reproductive Health; Special Programme of Research, Development and Research Training in Human Reproduction . Progestogen-only contraceptives during lactation: I. Infant growth. Contraception. 1994;50:35–53
  9. Jimenez J, Ochoa M, Soler MP, Portales P. Long-term follow-up of children breast-fed by mothers receiving depot-medroxyprogesterone acetate. Contraception. 1984;30:523–533
  10. Kennedy KI, Short RV, Tully MR. Premature introduction of progestin-only contraceptive methods during lactation. Contraception. 1997;55:347–350
  11. Queenan JT. Contraception and breastfeeding. Clin Obstet Gynecol. 2004;47:734–739
  12. Koetsawang S. The effects of contraceptive methods on the quality and quantity of breast milk. Int J Gynaecol Obstet. 1987;25(Suppl):115–127
  13. Baheiraei A, Ardsetani N, Ghazizadeh S. Effects of progestogen-only contraceptives on breast-feeding and infant growth. Int J Gynaecol Obstet. 2001;74:203–205
  14. ACOG practice bulletin. No. 73: use of hormonal contraception in women with coexisting medical conditions. Obstet Gynecol. 2006;107:1453–1472
  15. Culwell KR, Feinglass J. Changes in prescription contraceptive use, 1995–2002: the effect of insurance status. Obstet Gynecol. 2007;110:1371–1378
  16. Kelsey JJ. Hormonal contraception and lactation. J Hum Lact. 1996;12:315–318
  17. Guiloff E, Ibarra-Polo A, Zanartu J, Toscanini C, Mischler TW, Gomez-Rogers C. Effect of contraception on lactation. Am J Obstet Gynecol. 1974;118:42–45
  18. Karim M, Ammar R, el-Mahgoub S, el-Ganzoury B, Fikri F, Abdou I. Injected progestogen and lactation. Br Med J. 1971;1:200–203
  19. Patel SB, Toddywalla VS, Betrabet SS, et al. At what ‘infant-age’ can levonorgestrel contraceptives be recommended to nursing mothers?. Adv Contracept. 1994;10:249–255
  20. Virutamasen P, Leepipatpaiboon S, Kriengsinyot R, et al. Pharmacodynamic effects of depot-medroxyprogesterone acetate (DMPA) administered to lactating women on their male infants. Contraception. 1996;54:153–157
  21. Sas M, Gellen JJ, Dusitsin N, et al. An investigation on the influence of steroidal contraceptives on milk lipid and fatty acids in Hungary and Thailand. WHO Special Programme of Research, Development and Research Training in Human Reproduction. Task Force on Oral Contraceptives. Contraception. 1986;33:159–178
  22. New IPPF statement on breastfeeding, fertility and post-partum contraception. IPPF Med Bull. 1990;24:2–4
  23. Kaunitz AM. Injectable long-acting contraceptives. Clin Obstet Gynecol. 2001;44:73–91
  24. Kaunitz A. Depot medroxyprogesterone acetate for contraception—II. In:  Rose BD editors. Uptodate. Wellesley (MA): Uptodate; 2008;
  25. Xiang AH, Kawakubo M, Kjos SL, Buchanan TA. Long-acting injectable progestin contraception and risk of type 2 diabetes in Latino women with prior gestational diabetes mellitus. Diabetes Care. 2006;29:613–617
  26. Truitt ST, Fraser AB, Grimes DA, Gallo MF, Schulz KF. Combined hormonal versus nonhormonal versus progestin-only contraception in lactation. Cochrane Database Syst Rev. 2003;CD003988
  27. Culwell KR, Feinglass J. The association of health insurance with use of prescription contraceptives. Perspect Sex Reprod Health. 2007;39:226–230

PII: S0010-7824(09)00048-1

doi: 10.1016/j.contraception.2008.12.014

Contraception
Volume 80, Issue 1 , Pages 4-6 , July 2009

Article Tools